ClinicalTrials.gg
CompletedNCT05073705SELF-ADOLUpdated Apr 30, 2024

Self-management of HIV Among Adolescents

An interventional study of Empowerment and personal transformation intervention in HIV, sponsored by Mbarara University of Science and Technology. Completed at 1 site in Uganda. Open to participants aged 15 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-30.

Sponsored by Mbarara University of Science and Technology · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
15 Years to 24 Years
Sex
All
01

Study summary

There are over 73,000 adolescents living with HIV (ALHIV) in Uganda constituting 4% of the worldwide population of ALHIV. HIV remains a leading cause of death among adolescents despite widespread availability of antiretroviral medication. Generally, ALHIV have poor outcomes with higher rates of loss to follow up compared with other age groups. Mortality rates and loss to follow up are highest during the transition period. Transition success may be maximized for ALHIV who are better prepared to negotiate care in adult HIV clinic settings. This study proposes to develop a self-management intervention for ALHIV transitioning to adult HIV care and test the impacts of the intervention on HIV outcomes. Conducting the proposed studies in this application will complement my prior training in psychiatry while filling key gaps in three areas: (a) behavioral science theories and their application to behavioral interventions, (b) adaptation and design of behavioral interventions, and (c) testing of behavioral interventions through randomized trials. To fill these gaps, the investigators will conduct qualitative research to elaborate a conceptual framework of the barriers faced by ALHIV transitioning to adult HIV care in Uganda (Aim 1), develop a self-management intervention that will enable ALHIV to successfully transition to adult HIV care (Aim 2), and assess feasibility, acceptability, and preliminary effects of the self-management intervention on HIV outcomes for ALHIV transitioning to adult HIV care (Aim 3). This study will be the first to develop a self-management intervention targeting the critical transition period from pediatric to adult HIV care in sub-Saharan Africa and the first to use a randomized design to test the effect of a self-management intervention on health outcomes among ALHIV in Uganda who are transitioning to adult HIV care. These findings will have significant public health impact by optimizing health outcomes for a key population in the global HIV epidemic. The proposed research will serve as the basis for a competitive R01 grant proposal, submitted in year 4, to conduct a fully-powered, randomized controlled trial to evaluate the effectiveness of a behavioral intervention to improve retention in care and viral suppression among ALHIV in Uganda who are navigating the critical period of transition to adult HIV care.

Read the detailed description

HIV is a leading cause of mortality among adolescents living with HIV (ALHIV) in sub-Saharan Africa. Mortality among ALHIV is attributed to disengagement from care and poor adherence to HIV medications . Rates of retention in care and adherence to ART are lowest among ALHIV compared to other age groups. The risks of disengagement from care, being lost to follow up, and mortality rates are highest during the transition from pediatric to adult HIV care.

  1. Upon reaching adulthood, ALHIV should be transitioned to adult HIV care for age- and developmentally-appropriate medical care to maximize long term functioning . Perinatally infected ALHIV are dependent on pediatric HIV care providers and oftentimes family members, but will need to become self-reliant and manage their own health as they get older. However, ALHIV are often reluctant to transition to adult HIV care due to anticipated stigma, fear of disclosure, and/or lack of self-efficacy to assume responsibility for their own HIV care. Due to the challenges faced by ALHIV they need assistance with social and psychological skills to enable them to assume responsibilities related to their HIV care.
  1. ALHIV lack the necessary skills to negotiate care in adult HIV care settings. The majority of adolescents and young adults with chronic conditions do not have the necessary skills to negotiate their own care by the time they are transitioned to adult care. Myriad physical, psychological and social challenges that are characteristic of adolescence compounded by the need for peer acceptance and HIV stigma further complicate the adolescents' ability to cope with and manage HIV illness, thereby threatening their ability to advocate for themselves and seek care. In general, adolescents facing the transition to adult care may attain better health outcomes if they are prepared to negotiate care in adult clinic settings . Thus, there is need for developmentally tailored interventions to help ALHIV obtain the skills they need to successfully transition to adult HIV care.
  1. Self-management interventions have potential to facilitate successful transition to adult HIV care and also improve HIV outcomes. Self-management refers to the context and processes through which individuals and families use condition-specific knowledge, beliefs, and skills to achieve optimal health outcomes and health related quality of life. Self-management interventions are aimed at helping adolescents develop the skills and behaviors they need to transition to adulthood and independent living despite their chronic condition. Through self-management programs individuals gain information and skills related to their disease to increase self-efficacy and enable them to function independent of their parents and health care providers. Successful implementation of self-management programs has been linked to improved health outcomes while lack of self-management among individuals with chronic illness has been associated with increased mortality and decreased quality of life. Self-management interventions for HIV have been reported to have a positive impact on different aspects of HIV treatment outcomes including physical, psychological, and behavioral health outcomes . However, currently majority of the available self-management interventions were developed in high-income countries for other chronic conditions like spina bifida and diabetes and may not be appropriate for use among ALHIV. The few self-management interventions specific to HIV were developed for HIV-positive adults and may not be developmentally suited for ALHIV. Moreover, most HIV clinics in sub-Saharan Africa focus primarily on provision of medical services, with minimal or no attention paid to the social and psychological challenges of managing HIV as a chronic illness.

The study proposes to achieve the following aims:

Aim 1: Use qualitative research to develop a conceptual framework of the barriers faced by ALHIV transitioning to adult HIV care in Uganda. The investigators will conduct in-depth qualitative interviews with a purposive sample of ALHIV before adult HIV care transition (n=15) and after transition (including both those lost to follow-up and those successfully retained in care; n=15), caregivers (n=20), and healthcare providers (n=10). Interviews will focus on barriers to successful transition and potential facilitators and interventions.

Aim 2: Develop a self-management intervention that will enable ALHIV to successfully transition to adult HIV care. The initial content of the intervention will be based on the qualitative data from Aim 1. Based on my preliminary data and existing research, the investigators anticipate that the intervention will include 6 weekly sessions and involve elements of psychoeducation, cognitive behavioral strategies, self-efficacy training, problem solving, and resilience strengthening. Final intervention content will be refined in focus group discussions with ALHIV (n=10), caregivers (n=10), and health care providers (n=10).

Aim 3: Assess feasibility, acceptability, and preliminary effects of the self-management intervention on HIV outcomes for ALHIV transitioning to adult HIV care. The investigators will conduct a pilot randomized controlled trial with 80 ALHIV who will have been identified by their pediatric providers for transition to adult HIV care; 40 will be randomly assigned to the self-management intervention and 40 will be assigned to standard of care. Outcomes will be assessed at pre-intervention baseline, at 6 weeks (immediately post-intervention), and at 6 months post-intervention follow-up. The primary outcomes will be treatment adherence (based on pharmacy refill, pill count, and self-report), engagement in care, and adherence self-efficacy. Secondary outcomes will include acceptability and feasibility of the intervention, internalized/anticipated HIV stigma, depression, problem solving skills, quality of life, viral load suppression, and retention in care.

02

Conditions studied

  • HIV

Keywords

  • Transition readiness
  • self-management
  • retention in care
  • ART adherence
  • Adolescents
03

In context

Lead sponsor

Mbarara University of Science and Technology is the lead sponsor of 31 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Should be aged15-24 years
  2. Fully disclosed of their status
  3. live within 60 km of the clinic
  4. be able to provide assent or .

Exclusion criteria

Exclusion Criteria:

  1. Has not been fully disclosed to them
  2. Not physically strong enough (due to physical illness) to remain present for the duration of the interview
  3. Have difficulty fully understanding the interview questions due to cognitive impairments
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
80 participants (actual)

Study arms

  • No intervention
    Control Group

    Control condition: The control condition will be standard of care. This will include regular review in the clinic for medical refills and adherence counseling that will be given in the clinic as required and determined by the attending clinicians and the counselors in the HIV clinic. The clinic visits will be guided by the clinical status, availability of school programs, distance from the clinic, and ability to afford transport fare to the clinic.

  • Experimental
    Empowerment and personal transformation intervention

    Intervention/Treatment: The intervention to be delivered is the Empowerment and Personal Transformation (EPT) intervention. The EPT intervention is 6-session weekly intervention that will be given in groups. A closed group format of at least 8 participants will be used to maximize confidentiality and group cohesion. It involves elements of communication skills, empowerment and mindfulness, values and beliefs, trauma and healing, addresses issues of dependence and independence, and experiential therapy which addresses issues of emotional processing, resolution of conflicts from the past, and creative expression. The EPT intervention is 6-session weekly intervention that will be given in groups. Intervention content will be delivered by a degree level trained counselor at the MRRH HIV clinic following a manual.

    Behavioral: Empowerment and personal transformation intervention

Interventions

  • BehavioralEmpowerment and personal transformation intervention

    The intervention to be delivered is the Empowerment and Personal Transformation (EPT) intervention. The EPT intervention is 6-session weekly intervention that will be given in groups. A closed group format of at least 8 participants will be used to maximize confidentiality and group cohesion. It involves elements of communication skills, empowerment and mindfulness, values and beliefs, trauma and healing, addresses issues of dependence and independence, and experiential therapy which addresses issues of emotional processing, resolution of conflicts from the past, and creative expression. The EPT intervention is 6-session weekly intervention that will be given in groups. Intervention content will be delivered by a degree level trained counselor at the MRRH HIV clinic following a manual.

06

What researchers measure

Primary outcomes

  1. Mean adherence

    Treatment adherence based on unannounced pill counts. Pill count adherence will be calculated as (the number of pills dispensed) minus (number of pills counted) divided by (the number of pills expected to be taken) in the previous month.

    Time frame: 6 months

Secondary outcomes

  1. Mean transition readiness score

    The investigators will measure transition readiness using the HIV Adolescent Readiness for Transition Scale, which is a 15-item transition readiness scale that measures transition readiness among adolescents living with HIV.

    Time frame: 6 months

07

Study locations

1 site
  • Mbarara Regional Referral Hospital
    Mbarara, Uganda
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05073705
Lead sponsor
Mbarara University of Science and Technology
Responsible party
Sponsor
First posted
Oct 11, 2021
Start date
Aug 19, 2023
Primary completion
Mar 25, 2024
Completion
Apr 10, 2024
Last update
Apr 30, 2024

Study contacts

Scholastic Ashaba, MD, PhD
principal investigator · Mbarara University of Science and Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion